The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Woody hope you're well too.
As you I have a low average being in since the early days, I am mindful and I am ready to get hit or to make this investment journey a successful story.
I don't post but I am still invested and believe it will turn out good.
The significance of moving upwards today could have meant something.
I ll keep it for myself.
Everyone should know his chickens.
Good luck
The point was a commentary of the sp given that if we had broken the 156 level ( which i presume i know what you are invested in) there could have been a move upwards.
And also which mm dealt the trades, specifically those of the seller, which was still active and might be close to be cleared. Quite important things to know.
A tr1 will soon tell the story.
The question is whether the large trades from yesterday have cleared the seller or not which has been relentless the whole month.
Buyers happy te reload when seller initiate and viceversa.
We should see some movement wherever Polygon push the button if the seller is out.
Generally speaking, as a company grows, institutions will increase their ownership. Conversely, insiders often decrease their ownership over time.
Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index.
Investors should note that institutions actually own more than half the company, so they can collectively wield significant power.
Hedge funds own 9.9% of Synairgen. That worth noting, since hedge funds are often quite active investors, who may try to influence management. Many want to see value creation (and a higher share price) in the short term or medium term. Polygon Global Partners LLP is currently the largest shareholder, with 9.9% of shares outstanding. With 7.8% and 5.5% of the shares outstanding respectively, Polar Capital Holdings plc and UBS Asset Management are the second and third largest shareholders.
Insiders collectively own UK£7.0m worth of the UK£322m company. Some would say this shows alignment of interests between shareholders and the board.
The general public, with a 31% stake in the company, will not easily be ignored. While this group can't necessarily call the shots, it can certainly have a real influence on how the company is run.
Just a recap.
Looking at the trades executions I would think is Polygon that have carried on buying since the 10% was disclosed on August 6th.
An average of 4/500k daily and more buying some other days would bring it close to another 10mil shares bought since then.
They haven't have done their due diligence and the fact that they have increased by that much should bring some comfort in some shaky investors.
Let's see if we get a blue day tomorrow.
They are still buying and they should report crossing the 15% this or max next week imo.
The large trades this afternoon 275k 135k and 4x135k would suggest or at least would indicate thatthe buyer has scooped up the last shares of seller to be cleared.
GLA
Hope everyone is keeping well.
What I can say is that SNG by October ( maybe earlier) may well have a conditional preorder as well.
If so it will travel pari passu with other treatments and be succesfull on its own.
There's not a single silver bullet in this pandemic.
And a reminder..SNG001 doesn't mean only Covid-19 but also COPD and so on so mind what you saying.
SNG momentum is growing and it will continue to grow.
I d be happy if Merk will buy us out for 7/8+ billions.
GLA
I remember RM saying in the 18th November webinar that the next "significant" piece of news would have been the HT.
He added the results were expected in few weeks.
TW in the 30th of November webinar also said the results would have been ready in a cpls of weeks.
It was end of November then and the HT RNS came out 5 months later and it was "inconclusive"
Then you wander why the SP is where it is.
Too many naive people withing the SNG cult that can't see black from white.
When the full years results will be out dont be surprised if the SP will be at 75p if there are not news from the US.
Beside, if the Active-2 are not as good as people here think to be there's nothing left for SNG.
Not derampimg just looking at ot from a realistic point of view.
Mrbig and scinv they are not that wrong after all.
If an EUA will land at some point in the US I think more countries would follow suit ( i.e. India).
The question is always how many doses they can deliver and how the manufacturing aspect is advancing, which atm we don't know.
The company's target in terms of which patients would most benefit from receiving the drug is more clear and it will be clearer with the P3.
I presume they will move in that direction asap with relevant gov bodies, regulators etc.
An EUA in a country like India together with advancement in the ACTIVE-2 trial would quickly change sentiment with the investors but they have to move reasonably fast.
Chart wise yesterday was the perfect opportunity to get that gap closed and until some concrete news will be released the SP could go back below 1£. Quite simple in ny view.
I am not invested at the moment and for sure I won't rush myself into buying any share until things are clearer.
However, I see them succeding this year and many people think the same.
Yesterday news wasn't negative, but the high expectations were not met and the market reacted accordingly.
The positive thing is that more data is available which have shown safety and efficacy.
The results were not bad were "only" inconclusive given the majority of mild cases.
The play is still on and imo some positive announcements will land in the near term.
Until then many cautious investors will remain on the sidelines.
ATB